CRDA.L
$2652.00
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America.
Intraday
Recent News
Convatec stars as FTSE 100 closes with little change
It marked the second day in a row the index has closed much as it started, despite headwinds over US tariffs and fears over AI disruption.
FTSE 100 Live: Banks lead fallers amidst AI fears, Blue Owl spillover, US tariffs begin
FTSE 100 falls 8 points to 10,678 Banks hit by read-across from US finance sector falls Croda and ConvaTec top leaderboard after results 11.33am: Raspberry Pi keeps rebounding Raspberry Pi shares are up another 12%, having risen 64% over the past month (after falling 54% last year),...
Croda International H2 Earnings Call Highlights
Croda International (LON:CRDA) reported 2025 results showing higher sales, improved profits, and early progress from its transformation program, while outlining a three-year financial framework aimed at lifting margins and cash generation by 2028. 2025 results: growth despite uncertainty Management
Why The Narrative Around Croda International LSE CRDA Is Shifting After JPMorgan Model Updates
The latest research on Croda International has nudged fair value to £34.66 per share from £34.02, while also updating long term revenue growth from 4.34% to 4.33% and lifting the discount rate to 8.07% from 7.97%. Bullish voices see the revised price target as better aligned with the company’s current positioning and still allowing for some upside, whereas more cautious analysts point out that the uplift is mainly driven by model adjustments rather than fresh trading data. As this debate...
Investors Could Be Concerned With Croda International's (LON:CRDA) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...